Description
Mazdutide (also known as IBI362) is a novel dual-agonist peptide that targets both GLP-1 and glucagon receptors. It’s designed to enhance weight loss, improve glycemic control, and support cardiovascular health by reducing appetite, boosting energy expenditure, and improving lipid metabolism. Studies have shown its promising potential for individuals dealing with obesity and metabolic syndrome, making it a leading candidate in next-generation weight management therapies.
Reviews
There are no reviews yet.